Clinical trial

Helix Research Network

ID

Name

HRN 001

Description

The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.

Trial arms

Trial start

2021-09-13

Estimated PCD

2031-09-13

Trial end

2036-09-13

Status

Recruiting

Treatment

Exome sequencing

Exome sequencing will be completed on each sample submitted.

Size

2000000

Primary endpoint

Establish a Research Network

Through study completion, average 10 years

Aggregate data

Through study completion, average 10 years

Re-Contact participants

Through study completion, average 10 years

Genetic biomarker identification

Through study completion, average 10 years

Exploration of genetic determinants of disease

Through study completion, average 10 years

Collection and analysis of Patient Reported Outcomes

Through study completion, average 10 years

Eligibility criteria

Inclusion Criteria: * 18 years and older * Willing and able to comply with all aspects of the protocol Exclusion Criteria: * History of allogenic bone marrow transplant * History of allogenic stem cell transplant * Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'ECOLOGIC_OR_COMMUNITY', 'timePerspective': 'OTHER'}, 'enrollmentInfo': {'count': 2000000, 'type': 'ESTIMATED'}}

Updated at

2024-05-03

1 organization

1 product

2 indications

Organization

Product

Exome sequencing

Indication

Genetic Predisposition to Disease

Indication

Genetic Disease